Skip to content

Public FDA record

Z-3169-2024: Atellica CH Microalbumin_2 (ALB_2)-For in vitro diagnostic use in the quantitative measurement of microal

Recall record Z-3169-2024 for Siemens Healthcare Diagnostics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3169-2024
Company in FDA record
Siemens Healthcare Diagnostics, Inc.
FDA classification date
Sep 18, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Atellica CH Microalbumin_2 (ALB_2) and the ADVIA Chemistry Microalbumin_2 (ALB_2) are not meeting the High-Dose Hook Effect claim/Prozone Effect claim as stated in the Instructions for Use (IFU) on the Atellica CH, Atellica CI Analyzers, ADVIA 1800 Chemistry Systems, ADVIA 2400 Chemistry Systems, and ADVIA Chemistry XPT Systems, may result in erroneously depressed microalbumin patient results.

Source facts

Action
Siemens Healthcare issued Urgent Medical Device Corrections (UMDC) to US consignees ACHC24-05.A.US, ACHC24-05.A.US.CHC on 8/15/24 via FedX and Urgent Field Safety Notices (UFSN)to foreign consignees ACHC24-05.A.OUS, ACHC24-05.A.OUS.CHC to affected customers informing them of the issue and the impact to results. ADVIA Chemistry customers are advised that lot 665399 meets the IFU prozone claim. Customers will be instructed to discontinue use of and discard the impacted reagent lots indicated in the letter. Atellica CH customers will be advised that lots 242194, 242195, and 242321 meet the IFU prozone claim. Customers can continue to use the impacted products, with the understanding that patient samples with values above 9,500 mg/dL (95,000 mg/L) can result in falsely depressed results when using the impacted lots. Please retain this letter with your laboratory records and forward this letter to those who may have received this product. Resolution Lot 665399 meets the IFU prozone effect claim. The manufacturing control system has been updated to ensure that there is no impact to future lots. If you have any questions, please contact your Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative.
Initiated
2024-08-15
Root cause
Nonconforming Material/Component
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Austria, Bahamas, Bahrain, Bangladesh, Belgium, Bosnia Herzeg, Brazil, Canada, Chile, Colombia, Croatia, Cura¿ao, St. Eus, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hong¿Kong, Hungary, India, Indonesia, Iran, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lithuania, Malaysia, Maldives, Mexico, Morocco, Netherlands, New¿Zealand, Norway, Oman, P.R.¿China, Pakistan, Paraguay, Peru, Poland, Portugal, Qatar, Republic¿Korea, Romania, Russian¿Fed., Saudi¿Arabia, Serbia, Singapore, Slovakia, Slovenia, South¿Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, U.A.E, United¿Kingdom, Uruguay, Vietnam, Zaire. ¿¿¿¿¿¿
Recall number
Z-3169-2024
Recall status
Open, Classified
CDRH record ID
209753
FDA classified
2024-09-18
Recall event number
95218

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗